0001209191-23-059365.txt : 20231220 0001209191-23-059365.hdr.sgml : 20231220 20231220165635 ACCESSION NUMBER: 0001209191-23-059365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231218 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Noci Darlene CENTRAL INDEX KEY: 0001862148 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 231501967 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-18 0 0001861560 Nuvalent, Inc. NUVL 0001862148 Noci Darlene C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Development Officer 0 Class A Common Stock 2023-12-18 4 M 0 22601 1.08 A 22601 D Class A Common Stock 2023-12-18 4 M 0 11560 6.89 A 34161 D Class A Common Stock 2023-12-18 4 M 0 5839 14.40 A 40000 D Class A Common Stock 2023-12-18 4 S 0 40000 75.82 D 0 D Stock Option (Right to Buy) 1.08 2023-12-18 4 M 0 22601 0.00 D 2031-02-15 Class A Common Stock 22601 46201 D Stock Option (Right to Buy) 6.89 2023-12-18 4 M 0 11560 0.00 D 2031-04-29 Class A Common Stock 11560 14791 D Stock Option (Right to Buy) 14.40 2023-12-18 4 M 0 5839 0.00 D 2032-08-01 Class A Common Stock 5839 44161 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.40 to $76.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. The shares underlying this option vest as follows: 25% of the shares vested on August 1, 2023, and the remainder have vested or shall vest over the next three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Deborah A. Miller, attorney-in-fact 2023-12-20